Nuo Therapeutics
(OTC) AURX
Nuo Therapeutics Financials at a Glance
Market Cap
$43.80M
Revenue (TTM)
$4.13M
Net Income (TTM)
-$2.38M
EPS (TTM)
-$0.05
P/E Ratio
-18.09
Dividend
$0.00
Beta (Volatility)
-37.43 (Low)
Dividend
$0.00
Beta (Volatility)
-37.43 (Low)
Price
$0.90
Volume
14,515
Open
$0.90
Price
$0.90
Volume
14,515
Open
$0.90
Previous Close
$0.90
Daily Range
$0.90 - $1.04
52-Week Range
$0.84 - $3.23
Estimated Earnings Date
Jun 29, 2026
Dividend
$0.00
Beta (Volatility)
-37.43 (Low)
Price
$0.90
Volume
14,515
Open
$0.90
Previous Close
$0.90
Daily Range
$0.90 - $1.04
52-Week Range
$0.84 - $3.23
Estimated Earnings Date
Jun 29, 2026
AURX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nuo Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
10
CEO
David Emerson Jorden, CFA, MBA
Website
www.nuot.comHeadquarters
Houston, TX 77054, US
AURX Financials
Key Financial Metrics (TTM)
Gross Margin
65%
Operating Margin
-54%
Net Income Margin
-58%
Return on Equity
-1032%
Return on Capital
-4%
Return on Assets
-1%
Earnings Yield
-5.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$43.80M
Shares Outstanding
48.41M
Volume
14.52K
Avg. Volume
3.95K
Financials (TTM)
Gross Profit
$2.22M
Operating Income
-$2.52M
EBITDA
-$2.36M
Operating Cash Flow
-$864.97K
Capital Expenditure
-$274.76K
Free Cash Flow
-$1.14M
Cash & ST Invst.
$548.95K
Total Debt
$597.35K
Nuo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.30M
+168.8%
Gross Profit
$849.73K
+133.9%
Gross Margin
65.26%
N/A
Market Cap
$43.80M
N/A
Market Cap/Employee
$4.87M
N/A
Employees
9
N/A
Net Income
-$618.47K
+17.1%
EBITDA
-$405.27K
+45.6%
Quarterly Fundamentals
Total Cash
$263.83K
+374.0%
Total Debt
$1.10M
+645.4%
Accounts Receivable
$873.67K
+215.9%
Inventory
$248.54K
+150.6%
Long Term Debt
$1.03M
+1198.3%
Short Term Debt
$78.95K
-42.9%
Return on Assets
-1.23%
N/A
Return on Invested Capital
-3.85%
N/A
Free Cash Flow
-$785.12K
-244.3%
Operating Cash Flow
-$784.27K
-43073.8%